TORONTO, June 11 /CNW/ - Patheon Inc. (TSX: PTI) a global provider of
drug development and manufacturing services to the international
pharmaceutical industry, today announced it will expand the Manati, Puerto
Rico facility to add a dedicated high potency and controlled substance
manufacturing area. Patheon will invest a total of $2.8 million in this new
3,386ft(2) area that will include three manufacturing suites, air lock
containment areas, and humidity controlled air systems.
